|Bid||3.35 x 3000|
|Ask||4.68 x 1000|
|Day's Range||3.60 - 3.85|
|52 Week Range||2.72 - 5.56|
|Beta (3Y Monthly)||0.41|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 1, 2017 - Nov 6, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.05|
BALDWIN PARK, Calif., Oct. 9, 2018 /PRNewswire/ -- StemCyte, a global regenerative therapeutics company, and Fulgent Genetics (FLGT), a leading genetic testing company, are proud to announce a new partnership to offer comprehensive genetic testing to support the health of growing families. Two genetic tests, "Beacon Expanded Carrier Screening" and "Newborn Genetic Analysis (NGA)," will now be offered through StemCyte and powered by Fulgent Genetics.
Fulgent Genetics, Inc. (FLGT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
Zero-debt allows substantial financial flexibility, especially for small-cap companies like Fulgent Genetics Inc (NASDAQ:FLGT), as the company does not have to adhere to strict debt covenants. However, it also facesRead More...
Revenue totals $5.4 million, growing 16% year over year and 16% sequentially Billable tests delivered total 5,700, growing 47% year over year and 23% sequentially GAAP and non-GAAP gross margins each improve ...
NEW YORK, NY / ACCESSWIRE / August 6, 2018 / Fulgent Genetics, Inc. (NASDAQ: FLGT ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 6, 2018 at 4:30 PM Eastern Time. ...
NEW YORK, NY / ACCESSWIRE / May 7, 2018 / Fulgent Genetics, Inc. (NASDAQ: FLGT ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 7, 2018 at 4:30 PM Eastern Time. To ...
For long term investors, improvement in profitability and outperformance against the industry can be important characteristics in a stock. In this article, I will take a look at Fulgent GeneticsRead More...
Categories: Yahoo FinanceGet free summary analysis Fulgent Genetics, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Fulgent Genetics, Inc. – Invitae Corp., OncoSec Medical Incorporated, Natera, Inc. and NeoGenomics, Inc. (NVTA-US, ONCS-US, NTRA-US and NEO-US) that have also reported for this period. Highlights Summary ... Read more (Read more...)
NEW YORK, NY / ACCESSWIRE / November 6, 2017 / Fulgent Genetics, Inc. (NASDAQ: FLGT ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 6, 2017 at 5:00 PM Eastern ...